IOLCP vs MANGALAM: Stock Comparison

IOL CHEM AND PHARMA vs MANGALAM DRUG & CHEMUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

IOL CHEM AND PHARMA is the larger company by market capitalisation. IOL CHEM AND PHARMA shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

IOLCP leads 10; MANGALAM leads 0 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

IOLCPMANGALAM

Valuation lens

What price are you paying?

Market CapContext only
₹5,841 Cr
₹48 Cr
P/E RatioSame reading
32.86x
P/B RatioSame reading
3.07x
EPSIOLCP has the higher reading
₹2.2
₹-4.83
Book ValueContext only
₹61.27
₹65.11
Dividend YieldIOLCP has the higher reading
0.5%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
IOLCP is the larger company
₹5,841 Cr vs ₹48 Cr
EPS
IOLCP has higher earnings per share
₹2.2 vs ₹-4.83
Dividend Yield
IOLCP has a higher dividend yield
0.5% vs 0%
Revenue Growth (TTM YoY)
IOLCP has faster revenue growth
17.4% vs -7.5%
EPS Growth (TTM YoY)
IOLCP has faster EPS growth
69.7% vs 0%
Qtr Profit Growth
IOLCP has stronger quarterly profit growth
0.12% vs -1.13%
ROE
IOLCP has a higher ROE
7.65% vs -42.41%
ROCE
IOLCP has a higher ROCE
7.96% vs -15.52%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricIOLCPMANGALAM
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricIOLCPMANGALAM
Live Price₹199.95₹30.02
Day Change1.79%-0.92%
Volume52.92 L18,726
52-Week High₹202.99₹79.7
52-Week Low₹67.19₹22.8
Distance from 52W High-1.5%-62.33%

Valuation

MetricIOLCPMANGALAM
Market Cap₹5,841 Cr₹48 Cr
P/E Ratio32.86x
P/B Ratio3.07x
EPS₹2.2₹-4.83
Book Value₹61.27₹65.11
Dividend Yield0.5%0%

Growth

MetricIOLCPMANGALAM
Revenue Growth (TTM YoY)17.4%-7.5%
EPS Growth (TTM YoY)69.7%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0.12%-1.13%

Profitability & Leverage

MetricIOLCPMANGALAM
ROE7.65%-42.41%
ROCE7.96%-15.52%
Net Margin5.94%-19.13%
Operating Margin8.58%-13.66%
Debt to Equity0.07x0.99x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricIOLCPMANGALAM
Promoter Holding62.28% 4.8 pp35.65%
FII Holding4.87% 3.15 pp0.11% 0.21 pp
DII Holding0.43% 0.41 pp0%
Public Holding32.42% 8.36 pp64.24% 0.22 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: IOL CHEM AND PHARMA and MANGALAM DRUG & CHEM.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.